Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 2/20 | 0.39 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.39 |
| ▸ | APAF1 | O14727 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20670455 | 1.00 | ALDH1A1 (0.64) | ALDH1A1MAPTTDP1L3MBTL1KDM4E | |
| SCHEMBL21787892 | 0.91 | ALDH1A1 (0.54) | ALDH1A1MAPTTDP1L3MBTL1KDM4E | |
| SCHEMBL1792016 | 0.88 | ALDH1A1 (0.46) | ALDH1A1MAPTTDP1L3MBTL1KDM4E | |
| SCHEMBL193916 | 0.88 | ALDH1A1 (0.46) | ALDH1A1MAPTTDP1L3MBTL1KDM4E | |
| Ammonia Solution, Strong SCHEMBL28873134 | 0.85 | ALDH1A1 (0.43) | ALDH1A1MAPTTDP1L3MBTL1KDM4E | |
| Hydrochloric Acid SCHEMBL250009 | 0.85 | ALDH1A1 (0.43) | ALDH1A1MAPTTDP1L3MBTL1KDM4E | |
| Ammonia Solution, Strong SCHEMBL28763213 | 0.85 | ALDH1A1 (0.43) | ALDH1A1MAPTTDP1L3MBTL1KDM4E | |
| Water SCHEMBL8817645 | 0.85 | ALDH1A1 (0.43) | ALDH1A1MAPTTDP1L3MBTL1KDM4E | |
| SCHEMBL36869 | 0.85 | ALDH1A1 (0.72) | ALDH1A1MAPTTDP1L3MBTL1KDM4E | |
| SCHEMBL2389596 | 0.85 | ALDH1A1 (0.72) | ALDH1A1MAPTTDP1L3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220006020-A1 | DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2022-01-06 | — | — | US | disclosed |
| EP-3650438-A1 | DI-, TRI- AND TETRAPHENYLINDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2020-05-13 | — | — | EP | disclosed |
| US-20200075862-A1 | INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | DOTTIKON ES HOLDING AG (CH) | 2020-03-05 | — | — | US | disclosed |
| CN-105103327-B | Light-emitting element, compound, organic compound, display module, lighting module, light-emitting device, display device, lighting device, and electronic device | 株式会社半导体能源研究所 | 2018-09-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220006020-A1 | DI-, TRI- AND TETRAPHENYLINDANE DERIVATES AND THEIR USE IN ORGANIC ELECTRONICS | NR0B2, KCNJ2, TRRAP | ALDH1A1 2569/4885MAPT 2927/4885TDP1 2481/4885 |
| US-20200075862-A1 | INDANE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONICS | KCNJ2, KCNA2, CYP2J2 | ALDH1A1 1964/4885MAPT 3034/4885TDP1 3909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.